Microbot Medical Stock Today
| MBOT Stock | USD 2.80 0.04 1.45% |
PerformanceWeak
| Odds Of DistressSmall
|
Microbot Medical is selling for under 2.80 as of the 21st of October 2025; that is 1.45 percent increase since the beginning of the trading day. The stock's last reported lowest price was 2.72. Microbot Medical has about a 43 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 23rd of July 2025 and ending today, the 21st of October 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 25th of March 1992 | Category Healthcare | Classification Health Care |
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. The company has 67.16 M outstanding shares of which 4.54 M shares are now shorted by private and institutional investors with about 0.64 trading days to cover. More on Microbot Medical
Moving together with Microbot Stock
Moving against Microbot Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Microbot Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Harel Gadot | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Drugs (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsMicrobot Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Microbot Medical's financial leverage. It provides some insight into what part of Microbot Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Microbot Medical (MBOT) is traded on NASDAQ Exchange in USA and employs 20 people. Microbot Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 185.36 M. Microbot Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 67.16 M outstanding shares of which 4.54 M shares are now shorted by private and institutional investors with about 0.64 trading days to cover.
Microbot Medical currently holds about 9.29 M in cash with (8.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31.
Check Microbot Medical Probability Of Bankruptcy
Ownership AllocationMicrobot Medical maintains a total of 67.16 Million outstanding shares. Roughly 91.11 % of Microbot Medical outstanding shares are held by general public with 0.014 pct. owned by insiders and only 8.88 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Microbot Ownership Details
Microbot Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Goldman Sachs Group Inc | 2025-06-30 | 34 K | |
| Hilltop Holdings Inc | 2025-06-30 | 33.7 K | |
| Susquehanna International Group, Llp | 2025-06-30 | 31.8 K | |
| Scotia Capital Inc | 2025-06-30 | 22.8 K | |
| Xtx Topco Ltd | 2025-06-30 | 17.2 K | |
| Stifel Financial Corp | 2025-06-30 | 16.1 K | |
| Beacon Capital Management, Llc | 2025-06-30 | 16 K | |
| Citigroup Inc | 2025-06-30 | 14 K | |
| American Century Companies Inc | 2025-06-30 | 12.7 K | |
| Vanguard Group Inc | 2025-06-30 | 2.1 M | |
| Atlantic Trust Group, Llc | 2025-06-30 | 612 K |
Microbot Medical Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Microbot Medical market risk premium is the additional return an investor will receive from holding Microbot Medical long position in a well-diversified portfolio.
| Mean Deviation | 4.67 | |||
| Semi Deviation | 5.14 | |||
| Standard Deviation | 6.18 | |||
| Variance | 38.16 |
Microbot Stock Against Markets
Microbot Medical Corporate Management
| Naama Moav | Vice Resources | Profile | |
| Michael Lytle | Head Analytics | Profile | |
| Rachel Vaknin | Chief Officer | Profile | |
| Eyal MD | Chief Board | Profile |
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.